Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Vaccines are one of, if not the, most important developments in public health history, and despite nearly a century of data, ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...

Novavax said it was eligible to receive royalties in high teens to low twenties percent on Sanofi sales, up to $350 million ...

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Hallmarks of post-acute consequences of SARS-CoV-2 ...

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox.

Not all homes will distribute Wi-Fi signal equally. The fact is, where you place the router can hugely affect your wireless coverage. It may seem logical to have the router inside a cabinet and ...

Researchers from the School of Medicine and Health Sciences, the Milken Institute School of Public Health and the Medical Faculty Associates will launch a Phase Two study for Sanofi’s COVID-19 vaccine ...

People are being urged to book one of the hundreds of thousands of COVID booster appointments still available before the NHS scales down its vaccination programme and focuses on at-risk patients.

During the quarter, GSK did not record any sales from the COVID-19 booster vaccine, which was co-developed with Sanofi SNY. Core selling, general and administration (SG&A) costs rose 6% to £2.70 ...

More than 9.7 million people in England received a top-up vaccination during the most recent autumn booster campaign. Many pharmacies also sell the Covid jab privately. The autumn booster campaign ...